Skip to main content
Fig. 2 | Journal of Pharmaceutical Health Care and Sciences

Fig. 2

From: The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril

Fig. 2

Systolic blood pressure changes in SHR during 6-week oral administration. Systolic blood pressure changes in SHR during 6-week oral administration of enalapril monotherapy (■), concomitant enalapril and FMP (), or initial enalapril monotherapy supplemented by FMP from day 29 onwards (). The control group (♦) received distilled water. Values are presented as the mean ± SE (n = 5). *p < 0.05 vs control group at the same time point (one-way analysis of variance, followed by Bonferroni/Dunn or Scheffe multiple comparison tests)

Back to article page